MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.

Journal of Neuropathology and Experimental Neurology
Vilde Elisabeth MikkelsenSverre Helge Torp

Abstract

O6-methylguanine DNA methyltransferase (MGMT) promoter methylation is an important favorable predictive marker in patients with glioblastoma (GBM). We hypothesized that MGMT status could be a surrogate marker of pretreatment tumor biology observed as histopathological and radiological features. Apart from some radiological studies aiming to noninvasively predict the MGMT status, few studies have investigated relationships between MGMT status and phenotypical tumor biology. We have therefore aimed to investigate such relationships in 85 isocitrate dehydrogenase (IDH) wild-type GBMs. MGMT status was determined by methylation-specific PCR and was assessed for associations with 22 histopathological features, immunohistochemical proliferative index and microvessel density measurements, conventional magnetic resonance imaging characteristics, preoperative speed of tumor growth, and overall survival. None of the investigated histological or radiological features were significantly associated with MGMT status. Methylated MGMT status was a significant independent predictor of improved overall survival. In conclusion, our results suggest that MGMT status is not related to the pretreatment phenotypical biology in IDH wild-type GBMs. Furth...Continue Reading

References

Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Jan 16, 2007·Journal of Neuro-oncology·Emmanuelle CrinièreMarc Sanson
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marica EoliGaetano Finocchiaro
Dec 10, 2009·Nature Reviews. Neurology·Michael WellerMonika E Hegi
Jul 10, 2010·The Lancet Oncology·Nanne K KloosterhofMartin J van den Bent
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Jun 9, 2012·Neuro-oncology·Peter C HuszthyRolf Bjerkvig
Aug 4, 2012·The American Journal of Pathology·Matthew E Hardee, David Zagzag
Feb 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrea SottorivaSimon Tavaré
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Mar 12, 2015·Neuro-oncology·Anne Line StensjøenErik Magnus Berntsen
Nov 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·A Dullea, L Marignol
Apr 20, 2016·Experimental Cell Research·Jun-Hai TangSheng-Qing Lv
Jun 10, 2016·Medical Physics·Panagiotis KorfiatisBradley J Erickson
Sep 25, 2016·Acta Neuropathologica·Dusten UnruhCraig Horbinski
Mar 16, 2017·The New England Journal of Medicine·James R PerryUNKNOWN Trial Investigators
Mar 17, 2017·World Neurosurgery·Anne Line StensjøenOle Solheim
May 6, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S JakolaO Solheim
May 10, 2017·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Gliomas
Sep 20, 2017·Journal of Magnetic Resonance Imaging : JMRI·Yi-Bin XiHong Yin
Sep 28, 2017·World Neurosurgery·Vilde Elisabeth MikkelsenSverre Helge Torp
Sep 5, 2018·BMC Cancer·Vilde Elisabeth MikkelsenSverre Helge Torp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.